Outcomes Length of intervention in weeks (Median, (IQR)) · people with congenital heart disease.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiorespiratory fitness (CF) (mL/kg/min) · people with congenital heart disease.
1 finding from 1 review
Health‐related quality of life (HRQoL) · people with congenital heart disease.
1 finding from 1 review
Physical activity · people with congenital heart disease.
1 finding from 1 review
Submaximal cardiorespiratory fitness · people with congenital heart disease.
1 finding from 1 review
Muscle strength · people with congenital heart disease.
1 finding from 1 review
Adverse events (12 (12, 26)) · people with congenital heart disease.
1 finding from 1 review
Hospital admissions · people with congenital heart disease.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Objective measure of medication adherence: Cholesterol (low‐density lipoprotein) · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Objective measure of medication adherence: Blood pressure · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Combined cardiovascular events · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Adverse events · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Cognitive outcome: satisfaction with treatment · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Need for cardiac surgical interventions · people with endocarditis on the left side of the heart (on native or prosthetic valves) with bacteraemia for Streptococcus, Enterococcus…
It is very uncertain whether partial oral treatment changes need for cardiac surgicalinterventions compared with conventional intravenous treatment of endocarditis on the left side… (very low certainty).
1 finding from 1 review
Myocardial infarction · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (high dose) showed no clear difference in myocardial infarction compared with homocysteine‐lowering interventions (low dose) (moderate certainty).
1 finding from 1 review
Stroke · people with or without existing cardiovascular disease, men and women
It is very uncertain whether homocysteine‐lowering interventions (high dose) changes stroke compared with homocysteine‐lowering interventions (low dose) (very low certainty).
1 finding from 1 review
Death by any cause · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (high dose) showed no clear difference in death by any cause compared with homocysteine‐lowering interventions (low dose) (moderate certainty).
1 finding from 1 review
Cancer · people with or without existing cardiovascular disease, men and women
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for cardiac surgical interventions · people with endocarditis caused by Staphylococcus aureus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for cardiac surgical interventions · people with endocarditis due to Staphylococcus aureus in drug abusers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found